Pharmacodynamic Studies on Desogestrel Administered Alone and in Combination with Ethinylestradiol

References

• Andersson D C. Sex-hormone binding globulin. Clin Endocrinol 1974; 3: 69
   PubMedGoogle Scholar
• Andersson D C. The role of sex hormone binding globulin in health and disease. The Endocrine Function of the Human Ovary, V HT James, M Serio, G Giusti. Academic Press, London 1976; 141
   Google Scholar
• Andersson R N., Givens J R., Weiser W L., Umstot E S. Response of the binding capacity of plasma testosterone-estradiol-binding globulin to norethindrone and mestranol 0.1 mg in polycystic ovarian disease. Am J Obstet Gynecol 1976; 125: 166
   Google Scholar
• Barbosa J, Seal U S., Doe R P. Effect of anabolic steroids on hormone-binding proteins, serum Cortisol and serum nonprotein-bound Cortisol. J Clin Endocrinol 1971; 32: 232
   PubMedGoogle Scholar
• Bates G W., Whitworth N S. Effect of body weight reduction on plasma androgens in obese infertile women. Fertil Steril 1982; 38: 406
   PubMed Web of Science ®Google Scholar
• Bengtsson C. Ischemic heart disease in women. Acta Med Scand (Suppl) 1973; 549: 1
   Google Scholar
• Bergink E W. Binding of contraceptive progestogens to receptor proteins in human myometrium and MCF-7 cells. Br J Family Planning 1984; 10: 33
   Google Scholar
• Bergink E W., Crona N, Dahlgren E, Samsioe G. Effect of oestriol, oestradiol valerate and ethinyloestradiol on serum proteins in oestrogen deficient women. Maturitas 1981; 3: 241
   Google Scholar
• Bergink E W., Holma P, Pyörälä T. Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen binding. Scand J Clin Lab Invest 1981; 41: 663
   PubMed Web of Science ®Google Scholar
• Bradley J V. Distribution-free statistical tests. Prentice-Hall. 1968; 76
   Google Scholar
• Bradley D D., Wingerd J, Petitti D B., Krauss R M., Ramcharan S. Serum high-density lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. N Engl J Med 1978; 299: 17
   PubMed Web of Science ®Google Scholar
• Briggs M H. The beagle dog contraceptive steroids. Life Sciences 1977; 21: 175
   Google Scholar
• Briggs M H., Briggs M. Metabolic effects of hormonal contraceptives. 1980; 83, In: Symposium of recent advances in fertility regulation. Beijing 2–5 Sept
   Google Scholar
• Briggs M. Effect of oral progestogens on estrogen-induced changes in serum protein. Excerpta Medica Int Congr Ser 1974; 344: 35, The Second International Norgestrel Symposium (ed. Fairweather D VI)
   Google Scholar
• Bullock L P., Gupta C, Bardin C W. A mechanism for the antiandrogenic action of medrogestone. Int J Androl 1978; 1: 32
   Google Scholar
• Burr I M., Grant D B., Sozonenko P C., Kaplan S L., Grumbach M M. Some critical factors in double antibody radioprecipitating sera for measurement of human serum, LH, FSH and HGH. J Clin Endocrinol Metab 1969; 29: 948
   Web of Science ®Google Scholar
• Crona N, Silfverstolpe G, Samsioe G. Changes in serum apolipoprotein AI and sex-hormone binding globulin levels after treatment with two different progestins administered alone and in combination with ethinylestradiol. Diss University of Göteborg 1983
   Google Scholar
• Cullberg G, Adelgaard J, Nybo-Andersen J, et al. RestovarR-New low-dose, combined, oral contraceptive. Effects on serum proteins, free testosterone and clinical efficacy. Contracept Deliv Syst 1984; 5: 97
   Google Scholar
• Cullberg G, Eriksson O, Knutsson E, Steffensen K. Desogestrel, a new progestational compound. A comparative study, performed in ovariectomised women. Acta Obstet Gynecol Scand (Suppl) 1982; 111: 13
   Google Scholar
• Cullberg G, Lindstedt G, Mattsson L-Å, Steffensen K. Discordant effects on the concentrations of three plasma proteins by two gestagens in combination with ethinylestradiol. 1979, IX World Congress of Gynecology and Obstetrics, Tokyo, Abstract 333
   Google Scholar
• Cullberg G, Lundström R, Stenram U. Jaundice during treatment with an oral contraceptive, Lyndiol. Br Med J 1965; 1: 695
   PubMedGoogle Scholar
• Cullberg G, Lindstedt G, Lundberg P-A, Steffensen K. Central and peripheral effects of desogestrel 15–60 μg daily for 21 days in healthy female volunteers. Acta Obstet Gynecol Scand (Suppl) 1982; 111: 21
   Google Scholar
• Cullberg G, Samsioe G, Finstad-Andersen R, et al. Two oral contraceptives, efficacy, serum proteins and lipid metabolism. Contraception 1982; 26: 229
   PubMed Web of Science ®Google Scholar
• Cullberg J. Mood changes and menstrual symptoms with different gestagen/estrogen combinations. A double blind comparison with a placebo. Acta Psychiat Scand (Suppl) 1972; 236: 55
   Google Scholar
• Dericks-Tan J SE, Koch P, Taubert H D. Synthesis and release of gonadotropins: Effect of an oral contraceptive. Obstet Gynecol 1983; 62: 689
   Google Scholar
• Dewis P, Petsos P, Newman M, Anderson D C. The treatment of hirsutism with a combination of desogestrel and ethinyloestradiol. Clin Endocrinol 1985; 22: 29
   PubMed Web of Science ®Google Scholar
• Dickey R P., Stones S C. Progestational potency of oral contraceptives. Obstet Gynecol 1976; 47: 106
   Google Scholar
• Evans D J., Hoffman R G., Kalkhoff R K., Kissebah A H. Relationship of androgenic activity to body fat topography, fat cell morphology and metabolic aberrations in premenopausal women. J Clin Endocrinol Metab 1983; 57: 304
   PubMed Web of Science ®Google Scholar
• Glueck C J., Taylor H L., Jacobs D, Morrison J A., Beaglehole R, Williams O D. Plasma high-density lipoprotein cholesterol: Association with measurements of body mass. Circulation (Suppl IV) 1980; 62: 62
   Web of Science ®Google Scholar
• Goldzieher J W. Polycystic ovarian disease. Fertil Steril 1981; 35: 371
   PubMed Web of Science ®Google Scholar
• Goldzieher J W., Moses L E., Averkin E, Scheel C, Taber B Z. Nervousness and depression attributed to oral contraceptives: A double blind, placebo controlled study. Am J Obstet Gynecol 1971; 111: 1013
   PubMed Web of Science ®Google Scholar
• Guerero R, Aso T, Bteuer P F., et al. Studies on the pattern of circulating steroids in the normal menstrual cycle. Acta Endocrinol (Copenh) 1976; 81: 133
   Google Scholar
• Hammond G L., Langley M S., Robinson P A., Nummi S, Lund S. Serum steroid binding protein concentrations, distribution of progestogens and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel. Fertil Steril 1984; 42: 44
   PubMed Web of Science ®Google Scholar
• Hirvonen E, Mälkönen M, Manninen V. Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. N Engl J Med 1981; 304: 560
   PubMed Web of Science ®Google Scholar
• Hümpel M, Nieuweboer B, Wendt H, Speck U. Investigation of pharmacokinetics of ethinylestradiol to specific consideration of a possible first pass effect in women. Contraception 1979; 19: 421
   PubMedGoogle Scholar
• Jackson R L., Dockerty M B. The Stein-Leventhal syndrome. Analysis of 43 cases with special reference to association with endometrial carcinoma. Am J Obstet Gynecol 1975; 73: 161
   Google Scholar
• Johansson E DB. Depression of the progesterone levels in women treated with synthetic gestagens after ovulation. Acta Endocrinol (Copenh) 1971; 68: 779
   Google Scholar
• Judd H L., Yen S SC. Serum androstenedione and testosterone levels during the menstrual cycle. J Clin Endocrinol Metab 1973; 36: 475
   PubMed Web of Science ®Google Scholar
• van Kammen E, Thijssen J HH, Rademaker B, Schwartz F. The influence of hormonal contraceptives on sex hormone binding globulin (SHBG) capacity. Contraception 1975; 11: 53
   PubMed Web of Science ®Google Scholar
• Kamyab S, Fotherby K, Klopper A J. Metabolism of (4-14C) lynestrenol in man. J Endocrinol 1968; 42: 337
   Google Scholar
• Käär K, Rhen K, Tarkkila T. Short-term effects of desogestrel and ethinylestradiol on serum proteins in women. Scand J Clin Lab Invest 1984; 44: 623
   Google Scholar
• Laatikainen T J., Apter D L., Paavonen J A., Wahlström T R. Steroids in ovarian and peripheral venous blood in polycystic ovarian disease. Clin Endocrinol 1980; 13: 125
   PubMed Web of Science ®Google Scholar
• Larsson-Cohn U, Fáhreus L, Wallentin L, Zador G. Lipoprotein changes may be minimized by proper composition of a combined oral contraceptive. Fertil Steril 1981; 35: 115
   Google Scholar
• Larsson-Cohn U, Wallentin L, Zador G. Plasma lipids and high density lipoproteins during oral contraceptives with different combinations of ethinylestradiol and levonorgestrel. Horm Metab Res 1979; 11: 437
   Google Scholar
• Laurell C B., Kullander S, Thorell J. Effect of administration of a combined estrogen-progestin contraceptive on the level of individual plasma proteins. Scand J Clin Lab Invest 1968; 21: 337
   PubMed Web of Science ®Google Scholar
• Laurell C B., Rannevik G. A comparison of plasma protein changes induced by danazol, pregnancy and estrogens. J Clin Endocrinol Metab 1979; 49: 719
   PubMed Web of Science ®Google Scholar
• Levy R I. Cholesterol, apoproteins, and heart disease. Present status and future prospects. Clin Chem 1981; 27: 653
   PubMed Web of Science ®Google Scholar
• Lew E A., Garfinkel L. Variations in mortality by weight among 750000 men and women. J Chron Dis 1979; 32: 563
   PubMedGoogle Scholar
• Lindner H R., Bauminger S. Recent Progress in Reproductive Endocrinology, P G. Crossignani, V HT James. Academic Press, New York 1974; 193
   Google Scholar
• Lobo R A., Granger L, Goebelsman U, Mishell R M. Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO. J Clin Endocrinol Metab 1981; 52: 156
   PubMed Web of Science ®Google Scholar
• Lorenzo E M. Familial study of hirsutism. J Clin Endocrinol 1970; 31: 556
   PubMed Web of Science ®Google Scholar
• El Makhzangy M N., Wynn V, Lawrence M. Sex hormone binding globulin capacity as an index of oestrogenicity or androgenicity in women on oral contraceptive steroids. Clin Endocrinol 1979; 10: 39
   PubMedGoogle Scholar
• Mall-Haefeli M, Werner-Zodrow J, Huber P, Weijers M J. Klinische und biochemische Resultate bei der Behandlung mit Marvelon, einen neuen steroidalen Ovulationshemmer. Geburtsh u Frauenheilk 1982; 42: 215
   PubMed Web of Science ®Google Scholar
• Mattsson L-Å, Cullberg G, Lindstedt G. Ethinylestradiol administered by oral and sublingual routes: A comparative study in ovariectomised women. Horm Metab Res 1983; 15: 36
   Google Scholar
• Meisels A. The maturation value. Acta Cytol 1967; 11: 246
   Google Scholar
• Milewicz A, Silber D, Mielecki T. The origin of androgen synthesis in polycystic ovary syndrome. Obstet Gynecol 1983; 62: 601
   Google Scholar
• Mikhail G, Wu C H., Ferein M. Radioimmunoassay of plasma estrone and estradiol. Steroids 1970; 15: 333
   PubMed Web of Science ®Google Scholar
• Miller N E., Thelle D S., Förde O H., Mjös O D. The Tromsö heart study. High-density lipoprotein and coronary heart disease. A prospective case-control study. Lancet 1977; ii: 965
   Google Scholar
• Moghissi K S., Syner F N., McBride L L. Contraceptive mechanism of microdose norethindrone. Obstet Gynecol 1973; 41: 585
   PubMed Web of Science ®Google Scholar
• Musa B U., Seal U S., Doe R P. Elevation of certain plasma proteins in man following estrogen administration: A dose-response relationship. J Clin Endocrinol Metab 1965; 25: 1163
   PubMed Web of Science ®Google Scholar
• Nilsson L, Dennefors B, Olsson J H., Hillensjö T, Rannevik G. In vitro effect of danazol on steroidogenesis in developing human follicles. Acta Obstet Gynecol Scand (Suppl) 1984; 123: 99
   Google Scholar
• Odlind V, Elamsson K, Englund D E., Victor A, Johansson E DB. Effects of oestradiol on sex hormone binding globulin. Acta Endocrinol 1982; 101: 248
   PubMedGoogle Scholar
• Odlind V, Weiner E, Victor A, Johansson E DB. Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol. Br J Obstet Gynecol 1980; 87: 416
   PubMedGoogle Scholar
• Ottoson U-B. Oral progesterone and estrogen-progestogen therapy. Acta Obstet Gynecol Scand (Suppl) 1984; 127: 26
   Google Scholar
• Petrus M, Claverie J, Vancina S, Becue J, Dutan G, Rochiccioli P. Etude clinique, biologique, anatomique de 6 syndromes de Stein-Leventhal de l'adolescence. Arch Fr Pediatr 1981; 38: 417
   Google Scholar
• Plymate S R., Fariss B L., Basset M L., Matej L. Obesity and its role in polycystic ovary syndrome. J Clin Endocrinol Metab 1981; 52: 1246
   PubMed Web of Science ®Google Scholar
• Rosenfield R L. Studies of the relation of plasma androgen levels to androgen action in women. J Steroid Biochem 1975; 6: 695
   PubMedGoogle Scholar
• Royal College of General Practitioners' Oral Contraception study. Further analyses of mortality in oral contraceptive users. Lancet 1981; i: 541
   Google Scholar
• Saure A, Karjalainen O, Terävainen T. The effect of synthetic gestagens on progesterone formation in vitro in human corpus luteum of pregnancy. Eur J Obstet Gynecol Reprod Biol 1976; 6: 223
   Google Scholar
• Schiller H S., Petra P H. A filter assay for the corticosteroid binding globulin of human serum. J Steroid Biochem 1976; 7: 55
   PubMedGoogle Scholar
• Schneider W HF, Spona J, Schmid R, Lachnit-Fixon U. Efficacy of three phase oral contraceptives. In: International Symposium on Hormonal Contraception. Utrecht 10th Sept 1977. Excerpta Medica 1978; 126
   Google Scholar
• Schwartz U, Hammerstein J. The oestrogenic potency of various contraceptive steroids as determined by their effects on transcortin-binding capacity. Acta Endrocrinol (Copenh) 1974; 76: 159
   Google Scholar
• Shailaja G R., Madhwa H GR, Talbert L M., Sloan C, Hicks B. Normalization of testosterone levels using a low estrogen containing oral contraceptive in women with polycystic ovary syndrome. Obstet Gynecol 1982; 60: 15
   Google Scholar
• Siegberg R, Nilsson C G., Stenman V-H, Widholm O. Sex hormone profiles in oligomenorrhoic adolescent girls and the effect of oral contraceptives. Fertil Steril 1984; 41: 888
   Google Scholar
• Skouby S O. The influence on the pituitary-ovarian function, cervical mucus and vaginal cytology of a new progestational compound. Contraception 1976; 14: 529
   Google Scholar
• Speroff L, Glass R H., Kase N G. Clinical Gynecologic Endocrinology & Infertility, Third ed. 1983
   Google Scholar
• Taubert H D., Fischer H, Dericks-Tan J SE. Sensitivity changes of the pituitary during administration of a triphasic oral contraceptive. Benefits and risks of hormonal contraception, A A. Haspels, R Rolland, M A. Lancaster. MTP-Press. 1982; 143
   Google Scholar
• Stein I F., Leventhal M L. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29: 181
   Google Scholar
• Walton K W., Scott P J., Dykes P W., Davies J WL. The significance of alterations in serum lipids in thyroid dysfunction. II. Alterations of the metabolism and turnover of 131I-low density lipoproteins. Clin Sci 1965; 29: 217
   PubMed Web of Science ®Google Scholar
• Wang E, Shi S, Cekare S Z., Landgren B-M, Diczfalusy E. Hormonal consequences of “missing the pill”. Contraception 1982; 26: 545
   PubMedGoogle Scholar
• Vermeulen A, Verdonck L, van der Straeten M, Orie N. Capacity of the testosterone-binding globulin capacity in human plasma and influence of specific binding of testosterone on its metabolic clearance rate. J Clin Endocrinol Metab 1969; 29: 1470
   Web of Science ®Google Scholar
• Victor A, Johansson E DB. Effects of d-norgestrel induced decreases in sex hormone binding globulin capacity on the d-norgestrel levels in plasma. Contraception 1977; 16: 115
   Google Scholar
• Victor A, Weiner E, Johansson E DB. Sex hormone binding globuline. The carrier protein for d-norgestrel. J Clin Endocrinol Metab 1976; 43: 244
   Web of Science ®Google Scholar
• Wiest W G., Paulson J D., Keller D W., Warren J C. Free testosterone concentration in serum: A method for determination. Am J Obstet Gynecol 1978; 130: 321
   PubMedGoogle Scholar
• Viinikka L. Radioimmunoassay of a new progestagen, Org 2969 and its metabolite. J Steroid Biochem 1978; 9: 979
   Google Scholar
• de Visser J, de Jager E, de Jongh H P., van der Vies J, Zeelen F. Pharmacological profile of a new orally active progestational steroid, Org 2969. Acta Endocrinol (Suppl) (Copenh) 1975; 199: 405
   Google Scholar
• Witztum J, Schonfeld G. High density lipoprotein. Diabetes 1979; 28: 336
   Google Scholar
• Wortsman J, Singh K, Murphy J. Evidence for the hypothalamic origin of the polycystic ovary syndrome. Obstet Gynecol 1981; 58: 137
   Google Scholar
• Wortsman J, Soler N G. Abnormalities of fuel metabolism in the polycystic ovary syndrome. Obstet Gynecol 1982; 60: 342
   PubMed Web of Science ®Google Scholar
• Yen S SC. The polycystic ovary syndrome. Clin Endocrinol (Oxf) 1980; 12: 177
   PubMed Web of Science ®Google Scholar
• Ylistalo P, Laakso L, Viinikka L, Yliorkola O, Vihko R. Cyproterone acetate in the treatment of hirsutism. Acta Obstet Gynecol Scand 1981; 60: 399
   Google Scholar